Controller, apac, Asia Pacific, us corp, nyse, accounting, asia
Sector: Medical Devices
Seeking a Head of Accounting and Controllership for the high risk, high volatility Asia Pacific region of a medical devices company listed on the New York stock exchange.
cfo, finance director, pharma, pharmaceuticals, italy, southern europe, ftse, us corp
Sector: Pharmaceuticals
Working with a global pharmaceutical group to identify a CFO for the Italian business, which at the time was a $350m revenue. This company is highly demanding and seeks CFOs who can partner with the GM and yet succeed in an environment with limited processes and structure, who are capable of driving the business performance in a constructive and value-adding manner. In particular there was a challenge to increase finance business partnering …
healthcare, fra, Switzerland, global, accounting, accounting policy, cao, medical devices, medtech, nyse, us corp, reporting
Sector: Medical Devices
Hired a EMEA Head of global financial reporting & accounting for this $14bn New York listed medical devices corporation and to lead all accounting, accounting policy and reporting cycles in the region, reporting to Global.
cfo, finance director, hitech, germany, central europe, us corp, dach, high tech
Sector: Software
Working with a medium sized software reseller and implementer to hire a CFO for the Central European business. The parent company was owned by a provate equity investor hence the provision of financial information was under intense scrutiny.
cfo, finance director, pharma, pharmaceuticals, germany, central europe, ftse, us corp, dach
Sector: Pharmaceuticals
Working with a global pharmaceutical group to identify a CFO for the DACh (Germany, Austria, Switzerland) business, which at the time was a $700m revenue. This company is highly demanding and seeks CFOs who can partner with the GM and yet succeed in an environment with limited processes and structure, who are capable of driving the business performance in a constructive and value-adding manner. In particular there was a challenge to increase …
finance director, fbp, Switzerland, healthcare, medtech, nyse, us corp, europe, emea
Sector: Healthcare Products
Hired a Finance Director to work as a partner to the European General Manager and lead the P&L for this $250m division of a New York Stock Exchange listed company.
finance director, finance business partner, emea, europe, chemicals, hygiene, nyse, us corp, Switzerland
Sector: Hygience & Purity
Hired a Finance Director to work as a partner to the European General Manager and lead the P&L for this $200m division of a New York Stock Exchange listed company. The position leads Finance Managers in 6 markets with a central team of 3.
cluster, France, western europe, services, us corp, nyse, financial controller, fpa, chemicals
Sector: Sustainability & Purity
Hired the no.2 to the CFO for France, Belgium & the Netherland for an NYSE listed company with local sales of $750m. The key challenges for the FP&A Manager were to develop an improved KPI reporting system to better understand the impact of discounts and rebates in sales contracts, as well as manage the total country FP&A cycles. The management matrix employed by this company was highly ambiguous with ownership of the P&L shared …
cfo, finance director, cluster, France, western europe, services, us corp, nyse, chemicals
Sector: Sustainability & Purity
Hired the European Finance Director for a global business unit of an NYSE listed company, with regional sales of $150m. The key challenges for the CFO were many-fold. The management matrix employed by this company was highly ambiguous with ownership of the P&L shared with European countries therefore influencing skills were essential.
financial controller, controller, us corp, us gaap, revenue recognition, France
Sector: Medical Devices
Working with one of the world's largest companies to hire a US GAAP accounting specialist to partner with the commercial organisation and ensure the sales force was aware of the impact of revenue recognition and other concepts that would impact working capital and the balance sheet.
